Coronavirus

The recent outbreak of the coronavirus COVID-19 has quickly evolved from a local issue to a global crisis. In addition to the tragic human loss, the disease is having and will continue to have a profound economic impact. On this page we will be providing regular legal updates on issues affecting our clients’ businesses around the world. Below is a list of our published updates.

 

  • Antitrust/Competition
  • Reset
Alert
Grants of early termination of HSR waiting period temporarily suspended by DOJ and FTC – merging parties should expect to wait the full 30 days until further announcement
Alert
Primer: What Companies in the COVID-19 Vaccine Supply Chain Need to Know about the Defense Production Act
Alert
JFTC Public Comment Opportunity: Amendments to Rules for eliminating seals to promote online procedures
Alert
The European Commission starts two new studies into the mobile payment sector
Alert
COVID-19: Acquisition of more than 10% voting rights by non-EU/EEA foreign investors in French listed companies will be subject to fast-track FDI review
Alert
FDI Regimes - The impact of COVID-19 on deal-making
Alert
COVID-19: Global Government Financial Assistance Measures
Our global team can provide advice on eligibility for governmental financial assistance measures on a global basis. 
Alert
UK ushers in new foreign takeover restrictions for Coronavirus-critical businesses and national security activities
Alert
European Commission extends its COVID-19 State aid rules to recapitalisation and subordinated debt measures
Alert
COVID-19: Following the paths of Spain, and soon Germany, the French Government Further Strengthens Foreign Investments Control
Alert
The Mexican Competition Commission enacts emergency regulatory provisions governing service of process through e-mail during the pandemic
Alert
The CMA publishes new guidance on merger control in a time of COVID-19: Business as usual?
Alert
For COVID-19 Competitor Collaborations, DOJ Antitrust Division’s “Business Review Letter” Offers Easy and Likely Effective Antitrust Protection
Alert
A Re-awakening of the Failing Firm Defence in the EU in the Aftermath of COVID-19?
Alert
COVID-19 Triggers DOJ and State AG Initiatives, and a Proposed Federal Addition to United States’ Price Gouging Framework
Alert
Overview of Measures to Mitigate the Negative Economic Effects of the Coronavirus Crisis by European, Middle Eastern, and Asian Countries
Alert
European Commission adopts amendment to its emergency COVID-19 State aid rules
Alert
A Novel Antitrust Defense for COVID-19 Agreements:
Section 708 of the Defense Production Act
Alert
The Mexican antitrust commission issues hollow guidance on the application of the Mexican antitrust statute during the corona pandemic
Alert
CARES Act Provides No Relief from Antitrust Laws, but Deference on COVID-19-Related Coalitions from DOJ/FTC Will Be Fact-Specific
Alert
Impact of the CARES Act on the Medical Device Industry
Alert
Competitor Collaborations: Competition Agencies Respond to a Global Pandemic
Alert
Impact of the CARES Act on the Pharmaceutical and Medical Devices Industries
Alert
Global Merger Clearance: The First Week of the New Normal
Alert
European Commission publishes its emergency COVID-19 State aid rules and rapidly approves ten State aid schemes
Alert
Merger control in times of COVID-19. Time for a change
Article
Unlocking Platform Technology to Combat Health Pandemics
Alert
Beware of antitrust rules also in times of COVID-19
Alert
Coronavirus Aid for Companies in Difficulties – Unprecedented Response from KfW, German government and EU Commission
Alert
State aid response to COVID-19 crisis
Alert
Impact of COVID-19 on US and EU Merger Review and Enforcement